381 related articles for article (PubMed ID: 29596304)
21. Dysregulation of microRNA biogenesis and gene silencing in cancer.
Hata A; Lieberman J
Sci Signal; 2015 Mar; 8(368):re3. PubMed ID: 25783160
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.
Yan J; Ying S; Cai X
Biomed Res Int; 2018; 2018():2754941. PubMed ID: 29651425
[TBL] [Abstract][Full Text] [Related]
23. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.
Sotiropoulou G; Pampalakis G; Lianidou E; Mourelatos Z
RNA; 2009 Aug; 15(8):1443-61. PubMed ID: 19561119
[TBL] [Abstract][Full Text] [Related]
24. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
27. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.
Zhu X; Li Y; Shen H; Li H; Long L; Hui L; Xu W
FEBS Lett; 2013 Jan; 587(1):73-81. PubMed ID: 23178712
[TBL] [Abstract][Full Text] [Related]
28. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.
Valdés-Mora F; Locke WJ; Bandrés E; Gallego-Ortega D; Cejas P; García-Cabezas MA; Colino-Sanguino Y; Feliú J; Del Pulgar TG; Lacal JC
Oncotarget; 2017 Apr; 8(16):26755-26770. PubMed ID: 28460460
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
31. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
32. An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.
Marques CA; Hähnel PS; Wölfel C; Thaler S; Huber C; Theobald M; Schuler M
Blood; 2008 Feb; 111(3):1413-9. PubMed ID: 17971488
[TBL] [Abstract][Full Text] [Related]
33. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
34. MiR-106a: Promising biomarker for cancer.
Pan YJ; Zhuang Y; Zheng JN; Pei DS
Bioorg Med Chem Lett; 2016 Nov; 26(22):5373-5377. PubMed ID: 27780637
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-184 Modulates Human Central Nervous System Lymphoma Cells Growth and Invasion by Targeting iASPP.
Liang XG; Meng WT; Hu LJ; Li L; Xing H; Xie G; Wang AQ; Jia YQ
J Cell Biochem; 2017 Sep; 118(9):2645-2653. PubMed ID: 28012196
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs as therapeutic targets in chemoresistance.
Garofalo M; Croce CM
Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
[TBL] [Abstract][Full Text] [Related]
37. The caveolin-1 connection to cell death and survival.
Quest AF; Lobos-González L; Nuñez S; Sanhueza C; Fernández JG; Aguirre A; Rodríguez D; Leyton L; Torres V
Curr Mol Med; 2013 Feb; 13(2):266-81. PubMed ID: 23228128
[TBL] [Abstract][Full Text] [Related]
38. Effects of CDC42 on the proliferation and invasion of gastric cancer cells.
Du DS; Yang XZ; Wang Q; Dai WJ; Kuai WX; Liu YL; Chu D; Tang XJ
Mol Med Rep; 2016 Jan; 13(1):550-4. PubMed ID: 26549550
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
[TBL] [Abstract][Full Text] [Related]
40. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression.
Minard ME; Kim LS; Price JE; Gallick GE
Breast Cancer Res Treat; 2004 Mar; 84(1):21-32. PubMed ID: 14999151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
